QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

Congress cuts prescription copays for low-income seniors and disabled Medicare beneficiaries

H.R. 4139 — Cutting Copays Act · Filed by Morgan McGarvey (D-KY) · 1 cosponsor · Introduced Jun 25, 2025 · Referred to committee

85%
Transparency
Typical bill: 85%
5/100
Hidden-provision risk
Typical bill: 15/100
Low-Income Prescription Cost Relief

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill reduces out-of-pocket costs for low-income Medicare beneficiaries under Part D (prescription drug coverage). Starting immediately, it caps copays at $1 for generic and preferred multi-source drugs and $3 for other drugs. Beginning in 2026, generic drugs become free for low-income individuals, and other drugs revert to 2023 copay levels, then adjust annually for inflation.

Why we flagged it

The bill's sole operative mechanism is to reduce copay obligations for low-income Part D beneficiaries through lower fixed caps and eventual free generics. It is a straightforward entitlement expansion targeting a vulnerable population.

What the text implies

  • Pharmaceutical manufacturers may face reduced revenue from generic drugs if lower copays increase utilization among price-sensitive low-income beneficiaries, though the effect depends on demand elasticity.
  • Plan sponsors (insurers) administering Part D may experience margin pressure if copay reductions are not offset by CMS reimbursement adjustments or if utilization increases materially.
  • The 2026 transition to $0 copays for generics may accelerate generic drug uptake among low-income seniors, potentially improving medication adherence and reducing downstream medical costs.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Low-income Medicare beneficiaries—seniors and disabled individuals—directly benefit from lower copays and free generic drugs, reducing financial barriers to medication access. The bill imposes no new restrictions on citizens' rights or remedies; it only reduces their out-of-pocket burden.

Who stands to gain

  • low-income Medicare beneficiaries (seniors and disabled individuals)

Named in the bill

Centers for Medicare & Medicaid Services (CMS), Medicare Part D, Social Security Act, low-income individuals, generic drugs, preferred drugs, multiple source drugs

Where it stands

1 cosponsor: 1 Republicans.

  • Jun 25, 2025 — Introduced · Congress.gov: “Introduced in House”
  • Jun 25, 2025 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $3,010,000 in lobbying spend. A filing names 77 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

Morgan McGarvey, the sponsor, reported $628,638 in PAC receipts in the 2026 cycle.

  • America's Health Insurance Plans Inc (ahip) — $3,010,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.

How this was measured

Analysis — Quorum's AI read the bill text published by Congress.gov (1,269 characters) on Aug 24, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.

Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.

Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.

As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.

“Congress cuts prescription copays for low-income seniors and disabled Medicare beneficiaries” QuorumCivic. https://share.quorumcivic.app/bill/119/hr4139 Report an error

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record

The week in bills

One email, Sunday: what Congress passed, what it changed, and who paid.

One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.